Joint & Bone Conditions
The most extensively studied applications of BMAC — supported by landmark clinical trials with multi-year follow-up data.
Shoulder & Rotator Cuff
100% healing at 6 months vs. 67% surgery alone. 87% intact at 10 years vs. 44% in controls (Hernigou et al., 2014). BMA injected to tendon-bone junction during arthroscopic repair.
Knee Osteoarthritis
Statistically significant improvements in WOMAC pain, function, and VAS scores at 6 months (p<0.001) in 267 knees treated with a single Marrow Cellution BMA injection (Kuebler et al., 2022).
Hip — AVN & Osteoarthritis
94% success in Stage I & II (Hernigou & Beaujean, 2002). Evidence of lesion size reduction and reversal of condition at 24 months (Gangji et al., 2004).
Ankle & Talus Lesions
One-step arthroscopic technique combining BMA, autologous cancellous bone cores, and hyalofast membrane for osteochondral talus lesions (Becher et al.).
Elbow & Wrist
Targeted marrow delivery for chronic lateral epicondylitis, medial epicondylitis, and degenerative wrist conditions including TFCC injuries.
ACL & Ligament Injuries
BMA hydrates synthetic scaffold and packs bone tunnels in BPTB ACL reconstruction, improving graft integration and reducing donor-site morbidity (Scilia et al.).
Non-Union Fractures
88.3% bone union rate in 60 tibial non-union patients. Healing correlated with CFU count (>1,500/cc = 100% success). No complications (Hernigou et al., 2005).
Subchondral Insufficiency
Biologic subchondral augmentation using Marrow Cellution demonstrated as safe and effective for bone marrow lesions (BML) in the knee at 1-year follow-up (Gobbi et al., 2021).
Plantar Fasciitis & Foot
Targeted percutaneous delivery to the plantar fascia insertion — addressing the underlying degenerative pathology rather than masking symptoms.
Cervical & Lumbar Applications
Lumbar Fusion Augmentation
Cervos BMA delivers similar CFU doses as ICBG autograft without significant donor-site morbidity. Hydrates cancellous chips and synthetic graft for autograft-equivalent healing.
Cervical Disc Degeneration
BMA augmentation of cervical fusion procedures — supporting bony incorporation while reducing the need for iliac crest bone graft harvest and associated complications.
Non-Union at Fusion Sites
Percutaneous BMA injection to address failed or slow-healing fusion sites. Published literature supports efficacy in tibial shaft non-unions with CFU-count-dependent outcomes.
Beyond the Joint
Erectile Dysfunction
Marrow Cellution delivers 3,160±297 CFU/mL vs. 506±102 for centrifuge. ED index 3× better for the Marrow Cellution group. BMA promotes vascular regeneration (Bieri et al., 2020).
Critical Limb Ischemia
Leg amputation rate in centrifuge group was 34.5% vs. 5.3% in Marrow Cellution group. Death rate 8.6% vs. 0%. Superior angiogenic outcomes (Mazzanti et al.).
Cardiac Applications (Research)
Animal and human studies have shown BM-MNC concentrate can contribute to therapeutic angiogenesis in ischemic cardiac tissue. Human trials ongoing.
Natural Rejuvenation
Facial Rejuvenation
Autologous BMA-derived growth factors for facial volume restoration and skin texture improvement. 100% your own biology — no synthetic fillers.
Scalp & Hair Regeneration
Emerging evidence supports BMA application at the scalp for hair follicle regeneration. Growth factors and EPCs promote vascularity and follicle health.
Skin Regeneration & Scarring
Post-procedural healing acceleration and scar remodeling using autologous bone marrow concentrate applied topically or via micro-injection.
Ready to See If You’re a Candidate?
Schedule a free consultation — we’ll review your condition and give you an honest assessment.
Book My Consultation